NasdaqGS - Delayed Quote USD
AstraZeneca PLC (AZN)
68.81
+0.85
+(1.25%)
At close: May 16 at 4:00:00 PM EDT
68.87
+0.06
+(0.09%)
Pre-Market: 7:42:03 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 6 |
| Avg. Estimate | 1.14 | 1.11 | 4.51 | 5.05 |
| Low Estimate | 1.07 | 1.09 | 4.45 | 4.83 |
| High Estimate | 1.2 | 1.13 | 4.55 | 5.33 |
| Year Ago EPS | 0.99 | 1.04 | 4.11 | 4.51 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 20 | 23 |
| Avg. Estimate | 14.12B | 14.61B | 57.81B | 61.16B |
| Low Estimate | 13.63B | 14.31B | 56.62B | 57.85B |
| High Estimate | 14.79B | 14.89B | 58.82B | 65.2B |
| Year Ago Sales | 12.94B | 13.56B | 54.07B | 57.81B |
| Sales Growth (year/est) | 9.15% | 7.73% | 6.92% | 5.79% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.99 | 1.03 | 1.04 | 1.12 |
| EPS Actual | 0.99 | 1.04 | 1.04 | 1.25 |
| Difference | -0 | 0.01 | 0.01 | 0.13 |
| Surprise % | -0.38% | 1.13% | 0.84% | 11.59% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.14 | 1.11 | 4.51 | 5.05 |
| 7 Days Ago | 1.14 | 1.12 | 4.51 | 5.06 |
| 30 Days Ago | 1.13 | 1.12 | 4.48 | 5.1 |
| 60 Days Ago | 1.15 | 1.17 | 4.42 | 5.04 |
| 90 Days Ago | 1.1 | 1.16 | 4.47 | 5.61 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 3 | 2 |
| Up Last 30 Days | 1 | 1 | 4 | 3 |
| Down Last 7 Days | 1 | 1 | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AZN | 15.33% | 6.63% | 9.77% | 12.13% |
| S&P 500 | 13.31% | 2.67% | 7.78% | 13.74% |
Upgrades & Downgrades
| Upgrade | UBS: Neutral to Buy | 2/13/2025 |
| Upgrade | UBS: Sell to Neutral | 11/20/2024 |
| Upgrade | Erste Group: Hold to Buy | 9/11/2024 |
| Maintains | TD Cowen: Buy to Buy | 8/12/2024 |
| Maintains | Argus Research: Buy to Buy | 5/30/2024 |
| Initiated | Goldman Sachs: Buy | 5/30/2024 |
Related Tickers
NVS Novartis AG
109.59
+1.04%
GSK GSK plc
37.64
+1.34%
SNY Sanofi
51.68
+1.61%
BMY Bristol-Myers Squibb Company
46.75
+2.05%
AMGN Amgen Inc.
272.41
+1.15%
GILD Gilead Sciences, Inc.
102.50
+2.15%
MRK Merck & Co., Inc.
76.06
+1.68%
JNJ Johnson & Johnson
151.33
+1.15%
BIIB Biogen Inc.
125.59
+1.53%
ABBV AbbVie Inc.
184.02
+1.29%